Asporin was selected for further investigation based on the following criteria: (a) Asporin acts as an oncogene in pancreatic, colorectal, gastric, and prostate cancer (10); (b) The roles of asporin in thyroid cancer have not been reported based in searchers of PubMed or Google. This evidence concerns the gene ASPN and thyroid gland carcinoma.